PUBLISHER: Transparency Market Research | PRODUCT CODE: 1075525
PUBLISHER: Transparency Market Research | PRODUCT CODE: 1075525
Drug-device Combination Products Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028
Drug-device Combination Products Market - Scope of Report
TMR's report on the global drug-device combination products market studies past as well as current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2028. The report provides revenue of the global drug-device combination products market for the period 2017-2028, considering 2020 as the base year and 2028 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global drug-device combination products market during the forecast period.
The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the global drug-device combination products market.
Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global drug-device combination products market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global drug-device combination products market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global drug-device combination products market.
The report delves into the competitive landscape of the global drug-device combination products market. Key players operating in the global drug-device combination products market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global drug-device combination products market that have been profiled in this report.
Key Questions Answered in Drug-device Combination Products Market Report
What is the scope of growth of product companies in the global drug-device combination products market?
What will be the Y-o-Y growth of the global drug-device combination products market between 2017 and 2028?
What is the influence of changing trends in technologies on the global drug-device combination products market?
Will North America be the most profitable market for drug-device combination products providers?
Which factors are anticipated to hamper the growth of the global drug-device combination products market during the forecast period?
Which are the leading companies in the global drug-device combination products market?
Research Methodology
TMR has utilized a unique research methodology to conduct comprehensive research on the growth of the global drug-device combination products market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.
Secondary methods referred to by analysts during the production of the global drug-device combination products market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR's study on the drug-device combination products market as primary methods.
These primary and secondary methods have provided exclusive information during interviews, which serves as a validation from the drug-device combination products market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global drug-device combination products market with accuracy. The study also uses the top-down approach to assess the revenue for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR's estimates on future prospects of the global drug-device combination products market more reliably and accurately.
Table of Contents
1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Drug-device Combination Products Market
4. Market Overview
- 4.1. Introduction
- 4.1.1. Product Type Definition
- 4.1.2. Industry Evolution / Developments
- 4.2. Overview
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.4. Global Drug-device Combination Products Market Analysis and Forecast, 2017-2028
5. Key Insights
- 5.1. Key Mergers & Acquisitions
- 5.2. Technological Advancements
- 5.3. Covid19 Impact Analysis
- 5.4. Regulatory Scenario by Region/globally
6. Global Drug-device Combination Products Market Analysis and Forecast, by Product Type
- 6.1. Introduction & Definition
- 6.2. Key Findings / Developments
- 6.3. Market Value Forecast, by Product Type, 2017-2028
- 6.3.1. Drug Eluting Stents
- 6.3.1.1. Coronary Stents
- 6.3.1.2. Peripheral Vascular Stents
- 6.3.2. Infusion Pumps
- 6.3.2.1. Implantable Infusion Pumps
- 6.3.2.2. Ambulatory Infusion Pumps
- 6.3.3. Inhalers
- 6.3.3.1. Metered Dose Inhalers
- 6.3.3.2. Dry Powder Inhalers
- 6.3.3.3. Nebulizers
- 6.3.4. Orthopedic Combination Products
- 6.3.4.1. Bone Graft Implants
- 6.3.4.2. Antibiotic Loaded Bone Cement
- 6.3.5. Wound Care Combination Products
- 6.3.6. Photosensitizers
- 6.3.7. Others
- 6.3.1. Drug Eluting Stents
- 6.4. Market Attractiveness Analysis, by Product Type
7. Global Drug-device Combination Products Market Analysis and Forecast, by Region
- 7.1. Key Findings
- 7.2. Market Value Forecast, by Region
- 7.2.1. North America
- 7.2.2. Europe
- 7.2.3. Asia Pacific
- 7.2.4. Latin America
- 7.2.5. Middle East & Africa
- 7.3. Market Attractiveness Analysis, by Region
8. North America Drug-device Combination Products Market Analysis and Forecast
- 8.1. Introduction
- 8.1.1. Key Findings
- 8.2. Market Value Forecast, by Product Type, 2017-2027
- 8.2.1. Drug Eluting Stents
- 8.2.1.1. Coronary Stents
- 8.2.1.2. Peripheral Vascular Stents
- 8.2.2. Infusion Pumps
- 8.2.2.1. Implantable Infusion Pumps
- 8.2.2.2. Ambulatory Infusion Pumps
- 8.2.3. Inhalers
- 8.2.3.1. Metered Dose Inhalers
- 8.2.3.2. Dry Powder Inhalers
- 8.2.3.3. Nebulizers
- 8.2.4. Orthopedic Combination Products
- 8.2.4.1. Bone Graft Implants
- 8.2.4.2. Antibiotic Loaded Bone Cement
- 8.2.5. Wound Care Combination Products
- 8.2.6. Photosensitizers
- 8.2.7. Others
- 8.2.1. Drug Eluting Stents
- 8.3. Market Value Forecast by Country, 2017-2027
- 8.3.1. U.S.
- 8.3.2. Canada
- 8.4. Market Attractiveness Analysis
- 8.4.1. By Product Type
- 8.4.2. By Country
9. Europe Drug-device Combination Products Market Analysis and Forecast
- 9.1. Introduction
- 9.1.1. Key Findings
- 9.2. Market Value Forecast, by Product Type, 2017-2027
- 9.2.1. Drug Eluting Stents
- 9.2.1.1. Coronary Stents
- 9.2.1.2. Peripheral Vascular Stents
- 9.2.2. Infusion Pumps
- 9.2.2.1. Implantable Infusion Pumps
- 9.2.2.2. Ambulatory Infusion Pumps
- 9.2.3. Inhalers
- 9.2.3.1. Metered Dose Inhalers
- 9.2.3.2. Dry Powder Inhalers
- 9.2.3.3. Nebulizers
- 9.2.4. Orthopedic Combination Products
- 9.2.4.1. Bone Graft Implants
- 9.2.4.2. Antibiotic Loaded Bone Cement
- 9.2.5. Wound Care Combination Products
- 9.2.6. Photosensitizers
- 9.2.7. Others
- 9.2.1. Drug Eluting Stents
- 9.3. Market Value Forecast, by Country/Sub-region, 2017-2027
- 9.3.1. Germany
- 9.3.2. U.K.
- 9.3.3. France
- 9.3.4. Italy
- 9.3.5. Spain
- 9.3.6. Rest of Europe
- 9.4. Market Attractiveness Analysis
- 9.4.1. By Product Type
- 9.4.2. By Country
10. Asia Pacific Drug-device Combination Products Market Analysis and Forecast
- 10.1. Introduction
- 10.1.1. Key Findings
- 10.2. Market Value Forecast, by Product Type, 2017-2027
- 10.2.1. Drug Eluting Stents
- 10.2.1.1. Coronary Stents
- 10.2.1.2. Peripheral Vascular Stents
- 10.2.2. Infusion Pumps
- 10.2.2.1. Implantable Infusion Pumps
- 10.2.2.2. Ambulatory Infusion Pumps
- 10.2.3. Inhalers
- 10.2.3.1. Metered Dose Inhalers
- 10.2.3.2. Dry Powder Inhalers
- 10.2.3.3. Nebulizers
- 10.2.4. Orthopedic Combination Products
- 10.2.4.1. Bone Graft Implants
- 10.2.4.2. Antibiotic Loaded Bone Cement
- 10.2.5. Wound Care Combination Products
- 10.2.6. Photosensitizers
- 10.2.7. Others
- 10.2.1. Drug Eluting Stents
- 10.3. Market Value Forecast, by Country/Sub-region, 2017-2027
- 10.3.1. Japan
- 10.3.2. China
- 10.3.3. India
- 10.3.4. Australia & New Zealand
- 10.3.5. Rest of Asia Pacific
- 10.4. Market Attractiveness Analysis
- 10.4.1. By Product Type
- 10.4.2. By Country
11. Latin America Drug-device Combination Products Market Analysis and Forecast
- 11.1. Introduction
- 11.1.1. Key Findings
- 11.2. Market Value Forecast, by Product Type, 2017-2027
- 11.2.1. Drug Eluting Stents
- 11.2.1.1. Coronary Stents
- 11.2.1.2. Peripheral Vascular Stents
- 11.2.2. Infusion Pumps
- 11.2.2.1. Implantable Infusion Pumps
- 11.2.2.2. Ambulatory Infusion Pumps
- 11.2.3. Inhalers
- 11.2.3.1. Metered Dose Inhalers
- 11.2.3.2. Dry Powder Inhalers
- 11.2.3.3. Nebulizers
- 11.2.4. Orthopedic Combination Products
- 11.2.4.1. Bone Graft Implants
- 11.2.4.2. Antibiotic Loaded Bone Cement
- 11.2.5. Wound Care Combination Products
- 11.2.6. Photosensitizers
- 11.2.7. Others
- 11.2.1. Drug Eluting Stents
- 11.3. Market Value Forecast, by Country/Sub-region, 2017-2027
- 11.3.1. Brazil
- 11.3.2. Mexico
- 11.3.3. Rest of Latin America
- 11.4. Market Attractiveness Analysis
- 11.4.1. By Product Type
- 11.4.2. By Country
12. Middle East & Africa Drug-device Combination Products Market Analysis and Forecast
- 12.1. Introduction
- 12.1.1. Key Findings
- 12.2. Market Value Forecast by Product Type, 2017-2027
- 12.2.1. Drug Eluting Stents
- 12.2.1.1. Coronary Stents
- 12.2.1.2. Peripheral Vascular Stents
- 12.2.2. Infusion Pumps
- 12.2.2.1. Implantable Infusion Pumps
- 12.2.2.2. Ambulatory Infusion Pumps
- 12.2.3. Inhalers
- 12.2.3.1. Metered Dose Inhalers
- 12.2.3.2. Dry Powder Inhalers
- 12.2.3.3. Nebulizers
- 12.2.4. Orthopedic Combination Products
- 12.2.4.1. Bone Graft Implants
- 12.2.4.2. Antibiotic Loaded Bone Cement
- 12.2.5. Wound Care Combination Products
- 12.2.6. Photosensitizers
- 12.2.7. Others
- 12.2.1. Drug Eluting Stents
- 12.3. Market Value Forecast, by Country/Sub-region, 2017-2027
- 12.3.1. GCC Countries
- 12.3.2. South Africa
- 12.3.3. Rest of Middle East & Africa
- 12.4. Market Attractiveness Analysis
- 12.4.1. By Product Type
- 12.4.2. By Country
13. Competition Landscape
- 13.1. Market Player - Competition Matrix (by tier and size of companies)
- 13.2. Market Share Analysis, by Company, 2020
- 13.3. Company Profiles
- 13.3.1. Teva Pharmaceutical Industries Ltd.
- 13.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
- 13.3.1.2. Financial Analysis
- 13.3.1.3. Growth Strategies
- 13.3.1.4. SWOT Analysis
- 13.3.2. AbbVie, Inc.
- 13.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
- 13.3.2.2. Financial Analysis
- 13.3.2.3. Growth Strategies
- 13.3.2.4. SWOT Analysis
- 13.3.3. Abbott Laboratories
- 13.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
- 13.3.3.2. Financial Analysis
- 13.3.3.3. Growth Strategies
- 13.3.3.4. SWOT Analysis
- 13.3.4. Medtronic plc
- 13.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
- 13.3.4.2. Financial Analysis
- 13.3.4.3. Growth Strategies
- 13.3.4.4. SWOT Analysis
- 13.3.5. Kaleo, Inc.
- 13.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
- 13.3.5.2. Financial Analysis
- 13.3.5.3. Growth Strategies
- 13.3.5.4. SWOT Analysis
- 13.3.6. SINOMED
- 13.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
- 13.3.6.2. Financial Analysis
- 13.3.6.3. Growth Strategies
- 13.3.6.4. SWOT Analysis
- 13.3.7. Alcon, Inc.
- 13.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
- 13.3.7.2. Financial Analysis
- 13.3.7.3. Growth Strategies
- 13.3.7.4. SWOT Analysis
- 13.3.8. Boston Scientific Corporation
- 13.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
- 13.3.8.2. Financial Analysis
- 13.3.8.3. Growth Strategies
- 13.3.8.4. SWOT Analysis
- 13.3.9. Integer Holdings Corporation
- 13.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
- 13.3.9.2. Financial Analysis
- 13.3.9.3. Growth Strategies
- 13.3.9.4. SWOT Analysis
- 13.3.10. Teleflex Incorporated
- 13.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
- 13.3.10.2. Financial Analysis
- 13.3.10.3. Growth Strategies
- 13.3.10.4. SWOT Analysis
- 13.3.11. Bausch Health Companies Inc
- 13.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
- 13.3.11.2. Financial Analysis
- 13.3.11.3. Growth Strategies
- 13.3.11.4. SWOT Analysis
- 13.3.12. Haselmeier GmbH
- 13.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
- 13.3.12.2. Financial Analysis
- 13.3.12.3. Growth Strategies
- 13.3.12.4. SWOT Analysis
- 13.3.1. Teva Pharmaceutical Industries Ltd.
List of Tables
- Table 01: Global Drug-device Combination Products Market Value (US$ Mn) Forecast, by Product Type, 2017-2027
- Table 02: Global Drug-device Combination Products Market Value (US$ Mn) Forecast, by Region, 2017-2027
- Table 03: North America Drug-device Combination Products Market Value (US$ Mn) Forecast, by Country, 2017-2027
- Table 04: North America Drug-device Combination Products Market Value (US$ Mn) Forecast, by Product Type, 2017-2027
- Table 05: Europe Drug-device Combination Products Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
- Table 06: Europe Drug-device Combination Products Market Value (US$ Mn) Forecast, by Product Type, 2017-2027
- Table 07: Asia Pacific Drug-device Combination Products Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
- Table 08: Asia Pacific Drug-device Combination Products Market Value (US$ Mn) Forecast, by Product Type, 2017-2027
- Table 09: Latin America Drug-device Combination Products Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
- Table 10: Latin America Drug-device Combination Products Market Value (US$ Mn) Forecast, by Product Type, 2017-2027
- Table 11: Middle East & Africa Drug-device Combination Products Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
- Table 12: Middle East & Africa Drug-device Combination Products Market Value (US$ Mn) Forecast, by Product Type, 2017-2027
List of Figures
- Figure 01: Global Drug-device Combination Products Market Value Share Analysis, by Product Type, 2021 and 2027
- Figure 02: Global Drug-device Combination Products Market Attractiveness Analysis, by Product Type, 2021-2027
- Figure 03: North America Drug-device Combination Products Market Value (US$ Mn) Forecast, 2017-2027
- Figure 04: North America Drug-device Combination Products Market Value Share Analysis, by Country, 2021 and 2027
- Figure 05: North America Drug-device Combination Products Market Attractiveness Analysis, by Country, 2021-2027
- Figure 06: North America Drug-device Combination Products Market Value Share Analysis, by Product Type, 2021 and 2027
- Figure 07: North America Drug-device Combination Products Market Attractiveness Analysis, by Product Type, 2021-2027
- Figure 08: Europe Drug-device Combination Products Market Value (US$ Mn) Forecast, 2017-2027
- Figure 09: Europe Drug-device Combination Products Market Value Share Analysis, by Country/Sub-region, 2021 and 2027
- Figure 10: Europe Drug-device Combination Products Market Attractiveness Analysis, by Country/Sub-region, 2021-2027
- Figure 11: Europe Drug-device Combination Products Market Value Share Analysis, by Product Type, 2021 and 2027
- Figure 12: Europe Drug-device Combination Products Market Attractiveness Analysis, by Product Type, 2021-2027
- Figure 13: Asia Pacific Drug-device Combination Products Market Value (US$ Mn) Forecast, 2017-2027
- Figure 14: Asia Pacific Drug-device Combination Products Market Value Share Analysis, by Country/Sub-region, 2021 and 2027
- Figure 15: Asia Pacific Drug-device Combination Products Market Attractiveness Analysis, by Country/Sub-region, 2021-2027
- Figure 16: Asia Pacific Drug-device Combination Products Market Value Share Analysis, by Product Type, 2021 and 2027
- Figure 17: Asia Pacific Drug-device Combination Products Market Attractiveness Analysis, by Product Type, 2021-2027
- Figure 18: Latin America Drug-device Combination Products Market Value Share Analysis, by Country/Sub-region, 2021 and 2027
- Figure 19: Latin America Drug-device Combination Products Market Attractiveness Analysis, by Country/Sub-region, 2021-2027
- Figure 20: Latin America Drug-device Combination Products Market Attractiveness Analysis, by Product Type, 2021-2027
- Figure 21: Middle East & Africa Drug-device Combination Products Market Value Share Analysis, by Country/Sub-region, 2021 and 2027
- Figure 22: Middle East & Africa Drug-device Combination Products Market Attractiveness Analysis, by Country/Sub-region, 2021-2027
- Figure 23: Middle East & Africa Drug-device Combination Products Market Attractiveness Analysis, by Product, 2021-2027
